Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real‐world prospective study

BACKGROUND: The XANTUS study (NCT01606995) demonstrated low rates of stroke and major bleeding in patients with atrial fibrillation (AF) receiving rivaroxaban in clinical practice for the prevention of thromboembolic events (N = 6784). HYPOTHESIS: Because previous real‐world studies have not reporte...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Cardiol
Autori principali: Camm, A. John, Amarenco, Pierre, Haas, Sylvia, Bach, Miriam, Kirchhof, Paulus, Kuhls, Silvia, Lambelet, Marc, Turpie, Alexander G.G.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wiley Periodicals, Inc. 2020
Soggetti:
Clinical Investigations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724214/
https://ncbi.nlm.nih.gov/pubmed/32896928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23452
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi